BioHarvest Sciences Gross Margin 2020-2024 | BHST

Current and historical gross margin for BioHarvest Sciences (BHST) over the last 10 years. The current gross profit margin for BioHarvest Sciences as of June 30, 2024 is %.
BioHarvest Sciences Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2024-06-30 $0.02B $0.01B 47.37%
2024-03-31 $0.02B $0.01B 43.75%
2023-12-31 $0.01B $0.01B 38.46%
2023-09-30 $0.01B $0.00B 40.00%
2023-06-30 $0.01B $0.00B 33.33%
2023-03-31 $0.01B $0.00B 28.57%
2022-12-31 $0.01B $0.00B 16.67%
2022-09-30 $0.01B 0 0.00%
2022-06-30 $0.00B 0 0.00%
2022-03-31 $0.00B 0 0.00%
2021-12-31 $0.00B 0 0.00%
2021-09-30 $0.00B 0 0.00%
2021-06-30 $0.00B 0 nan%
2021-03-31 $0.00B 0 nan%
2020-12-31 $0.00B 0 nan%
2020-06-30 $0.00B 0 nan%
2020-03-31 $0.00B 0 nan%
Sector Industry Market Cap Revenue
Medical MED-BIOMED/GENE $0.098B $0.013B
BioHarvest Sciences Inc. is a biotech firm. It focused on leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions, within business verticals nutraceutical health and wellness products such as dietary supplements and development of plant cell-based Active Pharmaceutical Ingredients which focus on specific medical indications. BioHarvest Sciences Inc. is based in Vancouver, Canada.
Stock Name Country Market Cap PE Ratio
Primo Water (PRMB) United States $4.535B 35.81
P.A.M Transportation Services (PAMT) United States $0.430B 0.00
Rigetti Computing (RGTI) United States $0.325B 0.00
Alpha Cognition (ACOG) Canada $0.035B 0.00
Atlantic Coastal Acquisition II (ABP) United States $0.000B 0.00